Insider Trading History of Cui Jingrong Jean

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Cui Jingrong Jean since 2019. The trader's CIK number is 1772259. At the time of the last reporting, Cui Jingrong Jean was the Chief Scientific Officer of Turning Point Therapeutics, Inc.. (stock ticker symbol TPTX). Also see all insider trading activities at Turning Point Therapeutics, Inc..

Yearly summary of insider trading at Turning Point Therapeutics, Inc. (TPTX) by Cui Jingrong Jean

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2020	TPTX	0	$0	493,500	$26,447,372	109,164	$522,361
2019	TPTX	0	$0	243,000	$13,412,724	0	$0

Insider trading of Turning Point Therapeutics, Inc. (TPTX) by Cui Jingrong Jean

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2020-06-09	TPTX	Sale	9,500	65.70	624,150
2020-06-04	TPTX	Sale	18,500	65.56	1,212,915
2020-06-05	TPTX	Sale	18,500	64.44	1,192,195
2020-06-08	TPTX	Sale	18,500	63.26	1,170,310
2020-05-21	TPTX	Sale	7,000	59.99	419,930
2020-05-20	TPTX	Sale	7,000	60.02	420,119
2020-05-19	TPTX	Sale	7,000	57.77	404,376
2020-05-08	TPTX	Sale	11,500	53.92	620,057
2020-05-05	TPTX	Sale	18,500	53.92	997,520
2020-05-06	TPTX	Sale	18,500	52.84	977,447
2020-05-07	TPTX	Sale	18,500	52.99	980,315
2020-04-24	TPTX	Sale	7,000	51.30	359,079
2020-04-23	TPTX	Sale	7,000	52.55	367,885
2020-04-22	TPTX	Sale	7,000	52.02	364,175
2020-04-09	TPTX	Sale	11,500	47.79	549,619
2020-04-13	TPTX	Sale	708	49.84	35,288
2020-04-06	TPTX	Sale	18,500	43.43	803,418
2020-04-07	TPTX	Sale	18,500	44.76	828,060
2020-04-08	TPTX	Sale	18,500	46.51	860,490
2020-03-26	TPTX	Sale	11,500	46.87	538,947
2020-03-25	TPTX	Sale	17,792	45.88	816,296
2020-03-23	TPTX	Sale	7,000	38.20	267,400
2020-03-24	TPTX	Sale	7,000	42.20	295,365
2020-03-10	TPTX	Sale	18,500	42.45	785,380
2020-03-11	TPTX	Sale	18,500	41.74	772,227
2020-03-12	TPTX	Sale	7,000	36.47	255,290
2020-02-24	TPTX	Sale	7,000	53.91	377,405
2020-02-25	TPTX	Sale	7,000	52.00	364,000
2020-02-26	TPTX	Sale	7,000	51.84	362,880
2019-12-27	TPTX	Option Ex	38,080	4.16	158,412
2019-12-30	TPTX	Option Ex	16,864	5.12	86,343
2019-06-27	TPTX	Option Ex	54,220	5.12	277,606
2020-02-10	TPTX	Sale	18,500	62.95	1,164,482
2020-02-11	TPTX	Sale	18,500	63.45	1,173,917
2020-02-12	TPTX	Sale	18,500	66.10	1,222,850
2020-01-27	TPTX	Sale	7,000	57.64	403,501
2020-01-28	TPTX	Sale	7,000	58.40	408,779
2020-01-29	TPTX	Sale	7,000	59.05	413,329
2020-01-15	TPTX	Sale	11,500	53.34	613,467
2020-01-10	TPTX	Sale	18,500	56.95	1,053,575
2020-01-14	TPTX	Sale	18,500	53.27	985,439
2020-01-13	TPTX	Sale	18,500	53.27	985,495
2019-12-18	TPTX	Sale	18,500	59.10	1,093,350
2019-12-19	TPTX	Sale	18,500	61.09	1,130,072
2019-12-20	TPTX	Sale	11,500	63.35	728,525
2019-12-17	TPTX	Sale	18,500	61.55	1,138,638
2019-12-16	TPTX	Sale	11,500	58.14	668,575
2019-12-13	TPTX	Sale	11,500	56.18	646,104
2019-12-11	TPTX	Sale	11,500	53.53	615,595
2019-12-12	TPTX	Sale	11,500	54.00	620,965
2019-12-10	TPTX	Sale	11,500	54.70	629,084
2019-12-06	TPTX	Sale	50,890	50.84	2,587,502
2019-12-09	TPTX	Sale	11,500	55.60	639,400
2019-12-05	TPTX	Sale	56,110	51.95	2,914,914

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cui Jingrong Jean (Chief Scientific Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month